Skip to main content

Meet the Analyst: Dr. Tara Speranza, Bell Potter Analyst Part 2

Grady Wulff
February 23, 2023

Continue on to learn about the remaining stocks, Microba Life Sciences (ASX:MAP) and Monash IVF (ASX:MVF), as well as what to expect from these companies in 2023.

In this video, Dr. Tara discusses:
– (0:34) Impacts of Ferring’s FDA approval on Microba
– (5:30) Drivers behind Microba’s increase in revenue
– (7:12) What 2023 looks like for Monash IVF
– (8:39) Monash IVF’s rating
– (11:45) Monash IVF’s impact from legal action

Note: This interview was filmed on 7 February 2023.

Morning Bell 4 May

Jessica Amir
May 4, 2020

Weekly Wrap 1 May

Jessica Amir
May 1, 2020

Morning Bell 1 May

Jessica Amir
May 1, 2020

April Market Overview

Jessica Amir
April 30, 2020

Morning Bell 30 April

Jessica Amir
April 30, 2020

Morning Bell 29 April

Jessica Amir
April 29, 2020

Morning Bell 28 April

Jessica Amir
April 28, 2020
Ads

Bell Direct | SIMPLĂ‹ AS

Bell Direct
April 27, 2020

Morning Bell 27 April

Jessica Amir
April 27, 2020